People with drug-resistant tuberculosis continue to be deprived of the best-possible treatment in part because of high drug prices, according to Doctors Without Borders.

Global Fund, an international financing organisation focused on ending epidemics, is working with the Nigerian government to increase efforts in controlling the tuberculosis epidemic in the country.

A new study finds that a shorter course of drugs to prevent tuberculosis - one of the world's deadliest diseases - is effective and can safely be given  to people who are also being treated for the HIV virus that causes Aids. The pan-African, South Africa-based Arum Institute presented the findings at  the Conference on Retroviruses and Opportunistic Infections convened  in Seattle in the American state of Washington.

There have long been differences over the pricing of drugs crucial to combating disease in poorer countries, with international drugs companies, backed by Western governments, arguing they have to recover their research costs and Global South governments arguing that profits are being put ahead of people's lives. Laura Lopez Gonzalez reports for Bhekisisa on how a showdown ahead of the recent United Nations high-level